Bulk Manufacturer of Controlled Substances Registration, 63219-63220 [2016-22082]
Download as PDF
<![CDATA[
63219
Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices
to which the United States is a party
(including grand jury proceedings), or
for the purpose of securing compliance
with this Final Judgment, or as
otherwise required by law.
D. If at the time information or
documents are furnished by Defendants
to the United States, Defendants
represent and identify in writing the
material in any such information or
documents to which a claim of
protection may be asserted under Rule
26(c)(1)(G) of the Federal Rules of Civil
Procedure, and Defendants mark each
pertinent page of such material,
‘‘Subject to claim of protection under
Rule 26(c)(1)(G) of the Federal Rules of
Civil Procedure,’’ then the United States
shall give Defendants ten (10) calendar
days notice prior to divulging such
material in any legal proceeding (other
than a grand jury proceeding).
asabaliauskas on DSK3SPTVN1PROD with NOTICES
XI. No Reacquisition and Other
Prohibited Activities
Defendants may not (1) reacquire any
part of the Divestiture Assets, (2)
acquire any option to reacquire any part
of the Divestiture Assets or to assign the
Divestiture Assets to any other person,
(3) enter into any local marketing
agreement, joint sales agreement, other
cooperative selling arrangement, or
shared services agreement, or conduct
other business negotiations jointly with
the Acquirers with respect to the
Divestiture Assets, or (4) provide
financing or guarantees of financing
with respect to the Divestiture Assets,
during the term of this Final Judgment.
The shared services prohibition does
not preclude Defendants from
continuing or entering into agreements
in a form customarily used in the
industry to (1) share news helicopters or
(2) pool generic video footage that does
not include recording a reporter or other
on-air talent, and does not preclude
Defendants from entering into any nonsales-related shared services agreement
or transition services agreement that is
approved in advance by the United
States in its sole discretion.
XII. Retention of Jurisdiction
This Court retains jurisdiction to
enable any party to this Final Judgment
to apply to this Court at any time for
further orders and directions as may be
necessary or appropriate to carry out or
construe this Final Judgment, to modify
any of its provisions, to enforce
compliance, and to punish violations of
its provisions.
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
XIII. Expiration of Final Judgment
exercise all necessary functions with
Unless this Court grants an extension, respect to the promulgation and
this Final Judgment shall expire ten
implementation of 21 CFR part 1301,
years from the date of its entry.
incident to the registration of
manufacturers, distributors, dispensers,
XIV. Public Interest Determination
importers, and exporters of controlled
Entry of this Final Judgment is in the
substances (other than final orders in
public interest. The parties have
connection with suspension, denial, or
complied with the requirements of the
revocation of registration) has been
Antitrust Procedures and Penalties Act,
redelegated to the Deputy Assistant
15 U.S.C § 16, including making copies
Administrator of the DEA Office of
available to the public of this Final
Diversion Control (‘‘Deputy Assistant
Judgment, the Competitive Impact
Administrator’’) pursuant to section 7 of
Statement, and any comments thereon,
28 CFR part 0, appendix to subpart R.
and the United States’ responses to
In accordance with 21 CFR
comments. Based upon the record
1301.33(a), this is notice that on
before the Court, which includes the
November 18, 2015, Alcami Wisconsin
Competitive Impact Statement and any
Corporation, W130 N10497 Washington
comments and response to comments
Drive, Germantown, Wisconsin 53022
filed with the Court, entry of this Final
applied to be registered as a bulk
Judgment is in the public interest.
manufacturer of alfentanil (9737), a
Date: llllllllllllllllll basic class of controlled substance listed
in schedule II.
Court approval subject to procedures of
Antitrust Procedures and Penalties Act, 15
The company plans to manufacture
U.S.C. § 16
reference standards for distribution to
lllllllllllllllllllll their research and forensic customers.
United States District Judge.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–22086 Filed 9–13–16; 8:45 am]
BILLING CODE P
[FR Doc. 2016–22100 Filed 9–13–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Alcami
Wisconsin Corporation
ACTION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before November 14, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
DATES:
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
SUMMARY:
Company
FR Docket
Johnson Matthey, Inc ..............................................................................................................
Mallinckrodt, LLC .....................................................................................................................
American Radiolabeled Chemicals ..........................................................................................
Rhodes Technologies ..............................................................................................................
VerDate Sep<11>2014
20:55 Sep 13, 2016
Jkt 238001
PO 00000
Notice of registration.
Frm 00054
Fmt 4703
Sfmt 4703
81
81
81
81
FR
FR
FR
FR
3475 ............................
31959 ..........................
31960 ..........................
34371 ..........................
E:\FR\FM\14SEN1.SGM
14SEN1
Published
January 21, 2016.
May 20, 2016.
May 20, 2016.
May 31, 2016.
63220
Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices
Company
FR Docket
Sigma Aldrich Research Biochemicals, Inc .............................................................................
81 FR 38217 ..........................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted
registration as a bulk manufacturer to
the above listed persons.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 27,
2016, Halo Pharmaceutical, Inc., 30
North Jefferson Road, Whippany, New
Jersey 07981 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
[FR Doc. 2016–22082 Filed 9–13–16; 8:45 am]
BILLING CODE 4410–09–P
Dihydromorphine (9145) ...............
Hydromorphone (9150) ................
DEPARTMENT OF JUSTICE
I
II
The company plans to manufacture
Hydromorphone (9150) for distribution
to its customers. Dihydromorphine
(9145) is an intermediate in the
manufacture of Hydromorphone and is
not for commercial distribution.
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Halo
Pharmaceutical, Inc.
ACTION:
Schedule
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Notice of application.
[FR Doc. 2016–22074 Filed 9–13–16; 8:45 am]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before November 14, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DATES:
The
Attorney General has delegated her
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
Published
June 13, 2016.
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before October 14, 2016. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
October 14, 2016.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
February 26, 2016, United States
Pharmacopeial Convention, 12601
Twinbrook Parkway, Rockville,
Maryland 20852 applied to be registered
as an importer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
VerDate Sep<11>2014
20:55 Sep 13, 2016
Jkt 238001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
14SEN1
I
I
I
I
]]>Agencies
[Federal Register Volume 81, Number 178 (Wednesday, September 14, 2016)]
[Notices]
[Pages 63219-63220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22082]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as manufacturers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted for these
notices.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Johnson Matthey, Inc.......... 81 FR 3475..... January 21, 2016.
Mallinckrodt, LLC............. 81 FR 31959.... May 20, 2016.
American Radiolabeled 81 FR 31960.... May 20, 2016.
Chemicals.
Rhodes Technologies........... 81 FR 34371.... May 31, 2016.
[[Page 63220]]
Sigma Aldrich Research 81 FR 38217.... June 13, 2016.
Biochemicals, Inc.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted registration as a bulk manufacturer to
the above listed persons.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-22082 Filed 9-13-16; 8:45 am]
BILLING CODE 4410-09-P
